DOCSLIB.ORG

Cphi & P-MEC China Exhibition List展商名单version版本20170525

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Cphi & P-MEC China Exhibition List展商名单version版本20170525 CPhI & P-MEC China Exhibition List展商名单 Version版本 20170525 Booth/ Company Name/公司中英文名 Product/产品 展位号 SA TOURNAIRE E1A01 Sichuan HuaFaMei Enterprise Co Ltd E1A01 Anuh Pharma E1A03 Muromachi Chemicals Inc E1A04 NOF Corporation E1A05 ScinoPharm Taiwan Ltd E1A08 Azelis E1A18 EDQM/ Council of Europe E1A19 Orthodox Union E1A20 NGL FINE CHEM LIMITED E1A21 Doosan Corporation E1A23 Sarv Bio Labs Pvt Ltd E1A24 Lonza Biologics Inc E1A25 AMRI E1A36 Hetero Labs Limited E1B01 Toronto Research Chemicals Inc E1B02 Savior Lifetec Corporation E1B03 Leawell International Ltd E1B04 Chemwerth Inc. E1B06 Kingchem (Liaoning) Chemical Co., Ltd E1B08 F.I.S. – Fabbrica Italiana Sintetici SpA E1B10 Carbosynth Ltd E1B12 PhosphonicS E1B12 Dasan Medichem E1B18 深圳信立泰药业股份有限公司/Shenzhen Salubris E1B19 Pharmaceuticals Co., Ltd. Dongkook Pharmaceutical Co.,Ltd. E1B20 Sheffield a Kerry Group Business E1B21 Alkaloids Corporation E1B22 Cho-a Pharm Co Ltd. E1B23 DIA Pharmaceutical Co., Ltd. E1B24 BRENNTAG E1B26 Silicycle INC E1B27 Agno Pharma E1B28 Shin Nippon Yakugyo Co., Ltd E1C02 上海卡乐康包衣技术有限公司/Colorcon China E1C03 High Science Co Ltd E1C04 Fischer Chemicals AG E1C10 Sinoway Industrial Co.,Ltd. E1C10 Angelini A.C.R.A.F SPA E1C13 Bolon Pharmachem Co., Ltd. E1C21 Espee Group Innovators E1C22 Newchem Spa E1C23 Namiki Shoji Co., Ltd. E1C24 ZEON CORPORATION E1C25 OPKO HEALTH SPAIN S.L.U. E1C27 珠海联邦制药股份有限公司/The United E1D01 Laboratories International Holdings Ltd. Indena SpA E1D02 Supriya Lifescience Ltd. E1D03 常州艾柯轧辊有限公司/Leo Chemical (Hong Kong) E1D04 Co., Ltd BIOCND Inc. E1D06 Korea Pharmaceutical Traders Association E1D07 Kyongbo Pharmaceutical Co., Ltd. E1D08 Enzychem Lifesciences Corp. E1D09 IL YANG PHARM. E1D10 CKD Bio Corporation E1D11 Alchem International Pvt Ltd E1D14 上海贺利氏工业技术材料有限公司/Heraeus E1D15 Materials Technology Shanghai Ltd. Amano Enzyme China Ltd E1D16 SUNASIA CO., LTD. E1D17 ZF Polpharma SA E1D18 浙江凯普化工有限公司/Zhejiang ChemPacific E1D19 Chemical Co.,Ltd. ERBOZETA S.P.A. E1D22 Sanat Products Limited E1D26 Mediking Pharmaceutical Group Ltd. E1D28 Corel Pharma Chem E1D30 Chirogate International Inc. E1E01 Chunghwa Chemical Synthesis & Biotech Co., E1E01 Ltd. INIST ST CO., LTD. E1E06 HANLIM PHARM. CO., LTD. E1E07 AK & MN BioFarm Co., Ltd. E1E08 Ahngook Pharm E1E09 ILDONG Pharmaceutical Co., Ltd. E1E10 CTCBIO INC. E1E11 DCS Pharma AG E1E20 Merck Chemicals (Shanghai) Co.,Ltd E1E22 PHARMSOL GROUP E1E23 Chemcon E1E24 Lusochimica S.P.A. E1E25 RCA KG E1E26 JSC Olainfarm E1E27 Macco Organiques Spol. s.r.o. E1E28 浙江省化工进出口有限公司/Zhechem Co., Ltd. E1F01 IONS PHARMA. E1F02 Aarti Drugs Limited E1F03 Midas Pharma GmbH Shanghai Representative E1F05 Dongbang Future Tech & Life Co., Ltd. E1F06 Hanmi Pharm. Co., ltd. E1F07 CMG Pharmaceutical CO., LTD. E1F08 SINIL Pharmaceutical Co., Ltd. E1F09 AnyGen Co., Ltd. E1F10 NEXEL Co., Ltd. E1F11 Yonsung Fine Chemicals Co., Ltd. E1F12 EstechPharma Co., Ltd. E1F18 KOA Shoji Co., Ltd. E1F20 Ningbo Fengrui Fine Chemical Ltd. E1F20 APC Pharmaceutical & Chemical Ltd E1F21 Linnea SA E1F23 Novacyl Asia Pacific Ltd E1F26 Lipoid AG E1F27 VIRCHOW PETROCHEMICAL PVT. LTD E1F28 美国药典委员会/U.S. Pharmacopeia Convention E1F29 Caregen Co Ltd E1F30 庄信万丰（上海）催化剂有限公司/Johnson E1F34 Matthey (Shanghai) Catalyst Co., Ltd. 庄信万丰（烟台）化工产品有限公司/Johnson Matthey Research & Development (Yantai) Co., E1F34 Ltd. Chemsphere Technology E1G01 Everlight Chemical Industrial Corporation E1G02 Daewon Pharm E1G03 JEIL PHARMACEUTICAL CO., LTD E1G04 DAE HWA PHARMACEUTICAL CO., LTD. E1G05 Wooshin Labottach Co., Ltd. E1G06 Korea United Pharm Inc. E1G07 Myungmoon Pharm. Co., Ltd. E1G08 Roquette Management (Shanghai) Co., Ltd. E1G21 SCI Pharmtech, Inc E1G22 Louston International Inc. E1G24 Bachem AG E1G26 江苏圣泰科合成化学有限公司/Leading Hero Global E1G28 Holdings Ltd Albemarle E1G31 Lasa Laboratory E1G32 Rettenmaier(Shanghai) Fiber Trading Co.,Ltd. E1G34 抗病毒类、抗肿瘤类、抗感染类和甾体类中间 体、原料药和药物制剂及医药合约研发和加工 服务APIs and Finished products of ARV, 上海创诺医药集团有限公司/Shanghai Desano Oncology, Anti-infection and Hormone E1H01 Pharmaceuticals Co., Ltd. drugs and pharmaceutical CRO & CDMO service APIs and Finished products of ARV, Oncology, Anti-infection and Hormone 培他米松、地塞米松、泼尼松、泼尼松龙、甲drugs and pharmaceutical CRO & CDMO 泼尼龙、醋酸氢化可的松、螺内酯、氨基酸、 GCLE、7AVCA、头孢地尼、核黄素磷酸钠、 天津市医药集团有限公司/TIANJIN TIANFA 甲睾酮、阿替洛尔、尼莫地平、阿加曲班、尼 E1H16 PHARMACEUTICALS IMP.&EXP. CORP. 美舒利、阿德福韦酯、注射用氢化可的松、注 射用马来酸阿奇霉素、肝素钠注射液、注射用 尿激酶、黄芪皂苷I、II、III、番泻叶提取物、甜 菊糖苷、萝卜硫素。Betamethasone Base, 注射用青蒿琥酯,盐酸左旋咪唑,双氢青蒿素磷 酸哌喹片Artesunate for 桂林南药股份有限公司/Guilin Pharceutical Co.,Ltd. E1H18a Injection,Levamisole HydrochlorideArtesunate for Injection,Levamisole Hydrochloride 盐酸克林霉素,克林霉素磷酸酯,盐酸克林霉素 棕榈酸酯,恩替卡韦,盐酸依匹斯汀,盐酸格拉司 琼,盐酸米托蒽醌,盐酸文拉法辛,阿仑膦酸钠 重庆凯林制药有限公司/Chongqing Carelife Clindamycin HCl,Clindamycin E1H18b Pharmaceutical Co.,Ltd. Phosphate,Clindamycin Palmitate Hydrochloride,Entecavir,Epinastine Hydrochloride,Granisetron Hydrochloride,Mitoxantrone 氨甲环酸 富马酸喹硫平 盐酸氯米帕明 阿戈美 拉汀Tranexamic acid; Quetiapine 湖南洞庭药业股份有限公司/Hunan Dongting Fumarate; Clomipramine Hydrochloride; E1H18c Pharmaceutical Co.,Ltd. AgomelatineTranexamic acid; Quetiapine Fumarate; Clomipramine Hydrochloride; Agomelatine L-精氨酸,L-精氨酸盐酸盐,L-半胱氨酸盐酸盐一 水物,L-胱氨酸,L-组氨酸,L-组氨酸盐酸盐,L-亮氨 酸,L-酪氨酸L-Arginine, L-Arginine Hcl, L- 湖北新生源生物工程股份有限公司/ Histidine, L-Histidine Hcl, L-Cystine, L- Shine Star （Hubei）Biological Engineering E1H18d Cysteine Hcl Mono, L-Leucine, L-TyrosineL- Co.,Ltd. Arginine, L-Arginine Hcl, L-Histidine, L- Histidine Hcl, L-Cystine, L-Cysteine Hcl 培美曲塞二钠,度他雄胺,硼替佐米,罗库溴铵,醋Mono, L-Leucine, L-Tyrosine 酸阿比特龙,达比加群,卡格列净,卡非佐米,蔗糖 铁,阿普斯特,托法替布Pemetrexed 重庆医药工业研究院有限责任公司/Chongqing Disodium, Abiraterone acetate, E1H18e Pharmaceutical Research Institute Co., Ltd Bortezomib, Dutasteride, Iron sucrose, Canagliflozin, Carfilzomib, Apremilast, Tofacitinib, Dabigatran etexilate, Rocuronium Bromide,119302-20-4,119302- 江苏万邦生化医药集团有限责任公司/Wanbang E1H18f 胰岛素系列产品InsulinInsulin Biopharmaceuticals 利福平II,利福平,异烟肼,吡嗪酰胺胶囊/片,盐酸 乙胺丁醇胶囊/片,丙硫异烟胺肠溶片,异福胶囊/ 片,异福酰胺胶囊,乙胺吡嗪利福异烟片II,乙胺利 沈阳红旗制药有限公司 /Shenyang hongqi 福异烟片Rifampicin Capsule (II) E1H18g pharmaceutical Co.,ltd. ,Rifampicin Capsule,Isoniazid Tablet,PYRAZINAMIDE CAPSULE/TABLET ,Ethambutol hYDROCHLORIDE CAPSULE/TABLET ,PROTIONAMIDE ENTERIC- China Chinopharma Ltd. E1H20 赛诺菲（中国）投资有限公司上海分公司/Sanofi E1H22 LLC Velpharm E1H28 Biophore India Pharmaceuticals Pvt. Ltd. E1H29 麦肯锡公司/McKinsey&Company E1H37 Medieye Holding Co., Limited E1H38 Granules India Ltd E1H39 盐酸克林霉素,盐酸克林霉素棕榈酸酯,克林霉 素磷酸酯Clindamycin HCl,Clindamycin 浙江海翔药业销售有限公司/Zhejiang Hisoar E1K01 Palmitate HCl,Clindamycin Pharmaceutical sales Co.,Ltd. PhosphateClindamycin HCl,Clindamycin Palmitate HCl,Clindamycin Phosphate 苯磺阿曲库铵,酒石酸布托啡诺,卡培他滨,醋酸 卡泊芬净,塞来昔布,苯磺顺阿曲库铵,硫酸氢氯 吡格雷,达托霉素,地氟烷,盐酸右美托咪定,三水 江苏恒瑞医药股份有限公司/Jiangsu Hengrui 多西他赛,碘化油,依托泊苷,钆特酸葡胺,异环磷 E1K08 Medicine Co.,Ltd. 酰胺,碘克沙醇,碘佛醇,盐酸伊立替康,盐酸氯胺 酮,来曲唑,美司钠,奥美沙坦,奥沙利铂,七氟烷, 替加氟,替莫唑胺,托伐普坦,卡莫司汀,度他雄胺, 钆布醇,碘海醇,注射用醋酸卡泊芬净,注射用苯 江苏豪森药业集团有限公司/Jiangsu Hansoh E1K08 Pharmaceutical Group Co., Ltd. 甲基多巴,加巴喷丁,卡比多巴,依托度酸,普瑞巴 林 浙江手心制药有限公司/Zhejiang Chiral Medicine METHYLDOPA,GABAPENTIN,CARBIDOPA,ET E1K16 Chemicals Co.,Ltd ODOLAC,PREGABALINMETHYLDOPA,GAB APENTIN,CARBIDOPA,ETODOLAC,PREGAB ALIN 甲基多巴,加巴喷丁,卡比多巴,依托度酸,普瑞巴 林 浙江永太科技股份有限公司/Zhejiang Yongtai METHYLDOPA,GABAPENTIN,CARBIDOPA,ET E1K16 Technology Co.,Ltd. ODOLAC,PREGABALINMETHYLDOPA,GAB APENTIN,CARBIDOPA,ETODOLAC,PREGAB ALIN 维生素E,生物素,辅酶Q10, 盐酸万古霉素,替考 拉宁,米格列醇, 达托霉素, 替加环素Vitamin E,D- Biotin, CoQ10, Vancomycin HCl, 浙江医药股份有限公司/Zhejiang Medicine Co., Ltd. E1K18 Teicoplanin, Miglitol, Daptomycin, TigecyclineVitamin E,D- Biotin, CoQ10, Vancomycin HCl, Teicoplanin, Miglitol, Daptomycin, Tigecycline 头孢克肟,头孢地尼,氧氟沙星,左氧氟沙星,盐酸 环丙沙星,盐酸克林霉素,拉索拉唑,奥美沙坦,替 米沙坦,UDCA,尼扎替丁,伊贝沙坦, 氟比洛芬, 浙江横店普洛进出口有限公司/ZHEJIANG 洛索洛芬钠, 美索巴莫, 瑞巴派特, 盐酸金刚烷 E1K20 HENGDIAN APELOA IMP. &EXP.CO.,LTD 胺, 盐酸安非他酮, 盐酸多奈哌齐, 加巴贲丁, 氟 苯尼考, 碘海醇, 氯霉素, 中间体, 化工品 Cefixime, Cefdinir, Ofloxacin, 原料药：扑热息痛粉，扑热息痛颗粒，厄多司Levofloxacin, Ciprofloxacin HCl, 坦，高半胱氨酸硫内酯，橙皮甙，氨基葡萄糖 硫酸盐，葡萄糖酸盐，水飞蓟素等。制剂和片 浙江康乐药业股份有限公司/ZHEJIANG KANGLE 剂：聚明胶肽，法莫替丁，头孢泊肟酯，葡萄 E1K26 PHARMACEUTICAL CO.,LTD. 糖酸钙氯化钠，葡萄糖氯化钠，苯磺酸氨氯地 平片等。API: Paracetamol, Paracetamol DC, Erdosteine,Homocysteine thiolactone, hesperidin,Glucosamine 东阳光/HEC E1K28 Glenmark Pharmaceuticals Ltd. E1K30 宁夏大地循环发展股份有限公司/Ningxia Dadi E1K36 Circular Development Corp., Ltd. Chemical Weekly E1K37 SIGACHI INDUSTRIES PVT LTD E1K39 Concord Biotech Limited E1K40 C&EN/ACS Publications E1K45 Chiral Quest (Suzhou) Co.,Ltd. E1M36 Ruland Chemical Co.,Ltd. E1M46 因杜肯集团/Grupo Indukern E1M50 主营医药原料及其制剂,医药中间体及化学试剂 、生化药品、中药材、中成药、生物制品、医 药新技术以及有关医药来料加工、补偿贸易、 上海市医药保健品进出口有限公司/Shanghai 合作生产业务等。Chinese Medical Medicines & Health Products Import & Export E1N01 herbs,Chinese Palent drugs,Health Co., Ltd. products,Pharmaceuticals and their preparations, pharmaceutical 强力霉素,林可霉素,硫酸新霉素,维生素A,维生intermediates,Chemical 素B,维生素C,维生素D,三氯蔗糖,萘普生,克拉 霉素,扑热息痛,非那西汀Doxycycline 华中药业有限公司/Huazhong Pharmaceutical Hcl,Lincomycin,Neomycin E1N10 Co.,Ltd. sulphate,Vitamin A,Vitamin B,Vitamin C,Vitamin D,Sucralose,Naproxen,Clarithromycin,Par 南方制药,多西他赛,10-DABacetamol,PhenacetinDoxycycline III,GMP证书,美国 FDA认证.,紫杉醇,GMP药厂,盐酸苯达莫司汀, 来曲唑,伊马替尼south 福建南方制药股份有限公司/Fujian South pharma,Docetaxel,10-DAB III,GMP E1N12 Pharmaceutical Co.,Ltd. certificate,USFDA inspection,Paclitaxel,GMP plant,Bendamustine 更昔洛韦钠针剂,阿奇霉素针剂,左乙拉西坦针HCl,Letrozole,IImatinib mesylatesouth 剂,依替巴肽针剂,泮托拉唑钠针剂,万古霉素针 剂,伏立康唑针剂,特利加压素针剂,阿昔洛韦针 海南普利制药股份有限公司/Hainan Poly Pharm 剂,硝普钠针剂,比伐卢定针剂,达托霉素针剂,塞 E1N18 Co.,Ltd 替派针剂,林可霉素针剂,阿奇霉素干混,地氯雷 他定片/干混,双膜嘧啶片Ganciclovir Sodium for Injection ,Azithromycin for Injection ,Levetiracetam Injection ,Pantoprazole Clarivate Analytics E1N21 SUANFARMA Group E1N22 Morepen Laboratories Ltd E1N23 Quintiles
Load more

Recommended publications
  • The National Drugs List
    ^ ^ ^ ^ ^[ ^ The National Drugs List Of Syrian Arab Republic Sexth Edition 2006 ! " # "$ % &'() " # * +$, -. / & 0 /+12 3 4" 5 "$ . "$ 67"5,) 0 " /! !2 4? @ % 88 9 3: " # "$ ;+<=2 – G# H H2 I) – 6( – 65 : A B C "5 : , D )* . J!* HK"3 H"$ T ) 4 B K<) +$ LMA N O 3 4P<B &Q / RS ) H< C4VH /430 / 1988 V W* < C A GQ ") 4V / 1000 / C4VH /820 / 2001 V XX K<# C ,V /500 / 1992 V "!X V /946 / 2004 V Z < C V /914 / 2003 V ) < ] +$, [2 / ,) @# @ S%Q2 J"= [ &<\ @ +$ LMA 1 O \ . S X '( ^ & M_ `AB @ &' 3 4" + @ V= 4 )\ " : N " # "$ 6 ) G" 3Q + a C G /<"B d3: C K7 e , fM 4 Q b"$ " < $\ c"7: 5) G . HHH3Q J # Hg ' V"h 6< G* H5 !" # $%" & $' ,* ( )* + 2 ا اوا ادو +% 5 j 2 i1 6 B J' 6<X " 6"[ i2 "$ "< * i3 10 6 i4 11 6! ^ i5 13 6<X "!# * i6 15 7 G!, 6 - k 24"$d dl ?K V *4V h 63[46 ' i8 19 Adl 20 "( 2 i9 20 G Q) 6 i10 20 a 6 m[, 6 i11 21 ?K V $n i12 21 "% * i13 23 b+ 6 i14 23 oe C * i15 24 !, 2 6\ i16 25 C V pq * i17 26 ( S 6) 1, ++ &"r i19 3 +% 27 G 6 ""% i19 28 ^ Ks 2 i20 31 % Ks 2 i21 32 s * i22 35 " " * i23 37 "$ * i24 38 6" i25 39 V t h Gu* v!* 2 i26 39 ( 2 i27 40 B w< Ks 2 i28 40 d C &"r i29 42 "' 6 i30 42 " * i31 42 ":< * i32 5 ./ 0" -33 4 : ANAESTHETICS $ 1 2 -1 :GENERAL ANAESTHETICS AND OXYGEN 4 $1 2 2- ATRACURIUM BESYLATE DROPERIDOL ETHER FENTANYL HALOTHANE ISOFLURANE KETAMINE HCL NITROUS OXIDE OXYGEN PROPOFOL REMIFENTANIL SEVOFLURANE SUFENTANIL THIOPENTAL :LOCAL ANAESTHETICS !67$1 2 -5 AMYLEINE HCL=AMYLOCAINE ARTICAINE BENZOCAINE BUPIVACAINE CINCHOCAINE LIDOCAINE MEPIVACAINE OXETHAZAINE PRAMOXINE PRILOCAINE PREOPERATIVE MEDICATION & SEDATION FOR 9*: ;< " 2 -8 : : SHORT -TERM PROCEDURES ATROPINE DIAZEPAM INJ.
    [Show full text]
  • Upregulation of Peroxisome Proliferator-Activated Receptor-Α And
    Upregulation of peroxisome proliferator-activated receptor-α and the lipid metabolism pathway promotes carcinogenesis of ampullary cancer Chih-Yang Wang, Ying-Jui Chao, Yi-Ling Chen, Tzu-Wen Wang, Nam Nhut Phan, Hui-Ping Hsu, Yan-Shen Shan, Ming-Derg Lai 1 Supplementary Table 1. Demographics and clinical outcomes of five patients with ampullary cancer Time of Tumor Time to Age Differentia survival/ Sex Staging size Morphology Recurrence recurrence Condition (years) tion expired (cm) (months) (months) T2N0, 51 F 211 Polypoid Unknown No -- Survived 193 stage Ib T2N0, 2.41.5 58 F Mixed Good Yes 14 Expired 17 stage Ib 0.6 T3N0, 4.53.5 68 M Polypoid Good No -- Survived 162 stage IIA 1.2 T3N0, 66 M 110.8 Ulcerative Good Yes 64 Expired 227 stage IIA T3N0, 60 M 21.81 Mixed Moderate Yes 5.6 Expired 16.7 stage IIA 2 Supplementary Table 2. Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analysis of an ampullary cancer microarray using the Database for Annotation, Visualization and Integrated Discovery (DAVID). This table contains only pathways with p values that ranged 0.0001~0.05. KEGG Pathway p value Genes Pentose and 1.50E-04 UGT1A6, CRYL1, UGT1A8, AKR1B1, UGT2B11, UGT2A3, glucuronate UGT2B10, UGT2B7, XYLB interconversions Drug metabolism 1.63E-04 CYP3A4, XDH, UGT1A6, CYP3A5, CES2, CYP3A7, UGT1A8, NAT2, UGT2B11, DPYD, UGT2A3, UGT2B10, UGT2B7 Maturity-onset 2.43E-04 HNF1A, HNF4A, SLC2A2, PKLR, NEUROD1, HNF4G, diabetes of the PDX1, NR5A2, NKX2-2 young Starch and sucrose 6.03E-04 GBA3, UGT1A6, G6PC, UGT1A8, ENPP3, MGAM, SI, metabolism
    [Show full text]
  • (12) Patent Application Publication (10) Pub. No.: US 2006/0110428A1 De Juan Et Al
    US 200601 10428A1 (19) United States (12) Patent Application Publication (10) Pub. No.: US 2006/0110428A1 de Juan et al. (43) Pub. Date: May 25, 2006 (54) METHODS AND DEVICES FOR THE Publication Classification TREATMENT OF OCULAR CONDITIONS (51) Int. Cl. (76) Inventors: Eugene de Juan, LaCanada, CA (US); A6F 2/00 (2006.01) Signe E. Varner, Los Angeles, CA (52) U.S. Cl. .............................................................. 424/427 (US); Laurie R. Lawin, New Brighton, MN (US) (57) ABSTRACT Correspondence Address: Featured is a method for instilling one or more bioactive SCOTT PRIBNOW agents into ocular tissue within an eye of a patient for the Kagan Binder, PLLC treatment of an ocular condition, the method comprising Suite 200 concurrently using at least two of the following bioactive 221 Main Street North agent delivery methods (A)-(C): Stillwater, MN 55082 (US) (A) implanting a Sustained release delivery device com (21) Appl. No.: 11/175,850 prising one or more bioactive agents in a posterior region of the eye so that it delivers the one or more (22) Filed: Jul. 5, 2005 bioactive agents into the vitreous humor of the eye; (B) instilling (e.g., injecting or implanting) one or more Related U.S. Application Data bioactive agents Subretinally; and (60) Provisional application No. 60/585,236, filed on Jul. (C) instilling (e.g., injecting or delivering by ocular ion 2, 2004. Provisional application No. 60/669,701, filed tophoresis) one or more bioactive agents into the Vit on Apr. 8, 2005. reous humor of the eye. Patent Application Publication May 25, 2006 Sheet 1 of 22 US 2006/0110428A1 R 2 2 C.6 Fig.
    [Show full text]
  • First Reversals of Cognitive Decline in Alzheimer's Disease and Its
    1/12/2017 First Reversals of Cognitive Decline in Alzheimer’sSystems Therapeutics, Disease and its PresidentPrecursors, Obama, MCI and and the End ofSCI Alzheimer’s Disease Dale E. Bredesen, M.D. Augustus Rose Professor Easton Laboratories for Neurodegenerative Disease Research UCLA Founding President, Buck Institute “There is nothing that will prevent, reverse, or slow the progress of Alzheimer’s disease.” “Everyone knows someone who is a cancer survivor; no one knows an Alzheimer’s survivor.” 1 1/12/2017 30,000,000 patients in 2012 3rd leading cause (James, B. D. et al. Contribution of Alzheimer disease to mortality in the United States. Neurology 82, 1045-1050, doi:10.1212/WNL. 0240 (2014) Pres. Obama and NAPA, 2011 160,000,000 patients in 2050 2 1/12/2017 Women at the epicenter of the epidemic •65% of patients •60% of caregivers •More common than breast cancer 0 Cures 3 1/12/2017 Alzheimer’s Disease (AD) Therapeutic Landscape A production APPROVED A aggregation Donepezil (Aricept) A clearance Rivastigmine (Exelon) Tau aggregation/phosph Galantamine (Razadyne) Cholinergic drugs Tacrine (Cognex) Others Memantine (Namenda) PHASE 3 PHASE 2 PHASE 1 Solanezumab ELND005 PBT2 AL-108 GSK933776 NIC5-15 PF04360365 AF102B MABT5102A Bapineuzmab Valproate Bryostatin-1 Nicotinamide Talsaclidine EHT-0202 NP12 ACC001 UB311 Alzemed Antioxidant BMS708163 Lithium AN1792 R1450 Begacestat Semagacestat Statins ABT089 NGF CAD106 V950 PF3084014 AZD3480 SB742457 Flurizan Dimebon E2012 Huperzine-A PRX03140 CTS21166 Rosiglitazone EGCg EVP6124 PUFA MK0752 MEM3454 TTP448 Phenserine CHF5074 PF-04447943 Clinical Trial in AD terminated “Game of Throwns” (243/244) R.I.P. R.I.P. R.I.P.
    [Show full text]
  • WO 2012/044761 Al
    (12) INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property Organization International Bureau (10) International Publication Number (43) International Publication Date _ . 5 April 2012 (05.04.2012) WO 2012/044761 Al (51) International Patent Classification: (81) Designated States (unless otherwise indicated, for every A61K 47/48 (2006.01) kind of national protection available): AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BR, BW, BY, BZ, (21) International Application Number: CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, PCT/US201 1/053876 DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, (22) International Filing Date: HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, 29 September 201 1 (29.09.201 1) KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, (25) Filing Language: English NO, NZ, OM, PE, PG, PH, PL, PT, QA, RO, RS, RU, (26) Publication Langi English RW, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, (30) Priority Data: ZM, ZW. 12/893,344 29 September 2010 (29.09.2010) US (84) Designated States (unless otherwise indicated, for every (71) Applicant (for all designated States except US): UNI¬ kind of regional protection available): ARIPO (BW, GH, VERSITY OF NORTH CAROLINA AT WILMING¬ GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, SZ, TZ, TON [US/US]; 601 South College Road, Wilmington, UG, ZM, ZW), Eurasian (AM, AZ, BY, KG, KZ, MD, NC 28403 (US).
    [Show full text]
  • Companion Plants for Better Yields
    Companion Plants for Better Yields PLANT COMPATIBLE INCOMPATIBLE Angelica Dill Anise Coriander Carrot Black Walnut Tree, Apple Hawthorn Basil, Carrot, Parsley, Asparagus Tomato Azalea Black Walnut Tree Barberry Rye Barley Lettuce Beans, Broccoli, Brussels Sprouts, Cabbage, Basil Cauliflower, Collard, Kale, Rue Marigold, Pepper, Tomato Borage, Broccoli, Cabbage, Carrot, Celery, Chinese Cabbage, Corn, Collard, Cucumber, Eggplant, Irish Potato, Beet, Chive, Garlic, Onion, Beans, Bush Larkspur, Lettuce, Pepper Marigold, Mint, Pea, Radish, Rosemary, Savory, Strawberry, Sunflower, Tansy Basil, Borage, Broccoli, Carrot, Chinese Cabbage, Corn, Collard, Cucumber, Eggplant, Beet, Garlic, Onion, Beans, Pole Lettuce, Marigold, Mint, Kohlrabi Pea, Radish, Rosemary, Savory, Strawberry, Sunflower, Tansy Bush Beans, Cabbage, Beets Delphinium, Onion, Pole Beans Larkspur, Lettuce, Sage PLANT COMPATIBLE INCOMPATIBLE Beans, Squash, Borage Strawberry, Tomato Blackberry Tansy Basil, Beans, Cucumber, Dill, Garlic, Hyssop, Lettuce, Marigold, Mint, Broccoli Nasturtium, Onion, Grapes, Lettuce, Rue Potato, Radish, Rosemary, Sage, Thyme, Tomato Basil, Beans, Dill, Garlic, Hyssop, Lettuce, Mint, Brussels Sprouts Grapes, Rue Onion, Rosemary, Sage, Thyme Basil, Beets, Bush Beans, Chamomile, Celery, Chard, Dill, Garlic, Grapes, Hyssop, Larkspur, Lettuce, Cabbage Grapes, Rue Marigold, Mint, Nasturtium, Onion, Rosemary, Rue, Sage, Southernwood, Spinach, Thyme, Tomato Plant throughout garden Caraway Carrot, Dill to loosen soil Beans, Chive, Delphinium, Pea, Larkspur, Lettuce,
    [Show full text]
  • Mode of Action
    STROKE TBI DEMENTIA Mode of Action Reconnecting Neurons. Empowering for Life. NEW MULTI-MODAL THERAPIES FOR NEUROLOGICAL DISORDERS Sonic hedgehog (Shh) The Sonic Hedgehog (Shh) signalling pathway regulates the development Smoothened of organs including the organization of the brain. For example, the Shh (Smo) Patched (Ptch) activates the Gli complex, which is responsible for the expression of develop- mental genes underpinning neurorecovery and leading to an amplification of natural recovery. Gli Complex Gli Repressor Gli Activator Cerebrolysin activates the Shh pathway1 Cerebrolysin has a promoting effect on neurogenesis and oligodendrogenesis via stimulating the expression of the Shh signalling pathway. Cerebrolysin increases mRNA modulation of Shh and its receptors ‘Patched’ (Ptch) and ‘Smoothened’ (Smo). Shh PTCH Smo 5 * * 3 * 3 4 (n=9) (n=9) *p<0.05 (n=9) *p<0.05 *p<0.05 3 2 2 2 1 1 Fold changes (mean±SE) changes Fold (mean±SE) changes Fold 1 (mean±SE) changes Fold 0 0 0 0 20 0 20 0 20 CERE (µl/ml) CERE (µl/ml) CERE (µl/ml) Figure 1: Cerebrolysin stimulates the expression of the sonic hedgehog signalling pathway components in neural progenitor cells. Graphs show mRNA levels in an in vitro experiment. Studies confirm the important role of the sonic hedgehog pathway in post-stroke brain repair and functional recovery, and suggests the Shh pathway to be a possible target for prolongation of the therapeutic window after stroke.2 MAINTENANCE AND RECOVERY OF THE NEURONAL NETWORK Neurotrophic factors (NTFs) are signaling molecules that maintain, protect, and restore the neuronal network and ensure proper functioning of the brain.
    [Show full text]
  • Workbook Psychiatry and Narcology
    Kharkiv National Medical University Department of Psychiatry, Narcology and Medical Psychology WORKBOOK MANUAL FOR INDIVIDUAL WORK FOR MEDICAL STUDENTS PSYCHIATRY AND NARCOLOGY (Part 2) Student ___________________________________________________________ Faculty _________________________________________________________ Course _________________ Group _____________________________________ Kharkiv 2019 Затверджено вченою радою ХНМУ Протокол №5 від 23.05.2019 р. Psychiatry (Part 2) : workbook manual for individual work of students / I. Strelnikova, G. Samardacova, К. Zelenska – Kharkiv, 2019. – 103 p. Копіювання для розповсюдження в будь-якому вигляді частин або повністю можливо тільки з дозволу авторів навчального посібника. CLASS 7. NEUROTIC DISORDERS. CLINICAL FORMS. TREATMENT AND REHABILITATION. POSTTRAUMATIC STRESS DISORDER. TREATMENT AND REHABILITATION. Psychogenic diseases are a large and clinically varied group of diseases resulting from an effect of acute or long-term psychic traumas, which manifest themselves by both mental and somatoneurological disorders and, as a rule, are reversible. Psychogenic diseases are caused by a psychic trauma, i.e. some events which affect significant aspects of existence of the human being and result in deep psychological feelings. These may be subjectively significant events, i.e. those which are pathogenic for the majority of people. Besides, the psyche may be traumatized by conventionally pathogenic events, which cause feelings in an individual because of his peculiar hierarchy of values. Unfavorable psychogenic effects on the human being cause stress in him, i.e. a nonspecific reaction at the physiological, psychological and behavioural levels. Stress may exert some positive, mobilizing influence, but may result in disorganization of the organism activity. The stress, which exerts a negative influence and causes various disturbances and even diseases, is termed distress. Classification of neurotic disorders I.
    [Show full text]
  • Chapter 1 Definitions and Classifications for Fruit and Vegetables
    Chapter 1 Definitions and classifications for fruit and vegetables In the broadest sense, the botani- Botanical and culinary cal term vegetable refers to any plant, definitions edible or not, including trees, bushes, vines and vascular plants, and Botanical definitions distinguishes plant material from ani- Broadly, the botanical term fruit refers mal material and from inorganic to the mature ovary of a plant, matter. There are two slightly different including its seeds, covering and botanical definitions for the term any closely connected tissue, without vegetable as it relates to food. any consideration of whether these According to one, a vegetable is a are edible. As related to food, the plant cultivated for its edible part(s); IT botanical term fruit refers to the edible M according to the other, a vegetable is part of a plant that consists of the the edible part(s) of a plant, such as seeds and surrounding tissues. This the stems and stalk (celery), root includes fleshy fruits (such as blue- (carrot), tuber (potato), bulb (onion), berries, cantaloupe, poach, pumpkin, leaves (spinach, lettuce), flower (globe tomato) and dry fruits, where the artichoke), fruit (apple, cucumber, ripened ovary wall becomes papery, pumpkin, strawberries, tomato) or leathery, or woody as with cereal seeds (beans, peas). The latter grains, pulses (mature beans and definition includes fruits as a subset of peas) and nuts. vegetables. Definition of fruit and vegetables applicable in epidemiological studies, Fruit and vegetables Edible plant foods excluding
    [Show full text]
  • The Ndac (Neurology and Psychiatry) Held on 17.12.2011
    1. RECOMMENDATIONS OF THE NDAC (NEUROLOGY AND PSYCHIATRY) HELD ON 17.12.2011:- The NDAC (Neurology and Psychiatry) deliberated the proposals on 17.12.2011and recommended the following:- AGENDA DRUG NAME RECOMMENDATIONS NO. Global Clinical Trials The drug has not yet been studied / approved in the country in adults. The tools to assess the cognitive affects are also not included in the 1 Rufinamide protocol except CBCL (child behaviours check list) which is not adequate. In view of above, the proposal to conduct the study in children 1 to 4 years of age was not recommended. DEFFREED Recommended for granting permission for the conduct of proposed study subject to following conditions: That subject from extension study 01050256 2 Lurasidone HCl should only be rolled over to the proposed study. Patients aged 18 to 65 years only should be included in the study. Since the study involves use of placebo without rescue medication in one arm in patients with 3 OPC-34712 acute schizophrenia, the proposal was not recommended for grant of permission. Since the study involves use of placebo without rescue medication in one arm in patients with 4 OPC-34712 acute schizophrenia, the proposal was not recommended for grant of permission. Recommended for granting permission for the 5 BMS-820836 conduct of proposed study. Patients aged 18 to 65 years only should be included in the study. Recommended for granting permission for the 6 BMS-820836 conduct of proposed study. Patients aged 18 to 65 years only should be included in the study. There were earlier studies conducted in USA which had failed as there was no statistically significant effect of the study drug at dose level of 5, 10 mg per day over placebo.
    [Show full text]
  • Identification of Potentially Inappropriate Medications with Risk
    Journal name: Clinical Interventions in Aging Article Designation: Original Research Year: 2019 Volume: 14 Clinical Interventions in Aging Dovepress Running head verso: Aguiar et al Running head recto: Aguiar et al open access to scientific and medical research DOI: 192252 Open Access Full Text Article ORIGINAL RESEARCH Identification of potentially inappropriate medications with risk of major adverse cardiac and cerebrovascular events among elderly patients in ambulatory setting and long-term care facilities This article was published in the following Dove Medical Press journal: Clinical Interventions in Aging João Pedro Aguiar1 Purpose: Cardiovascular diseases (CVDs) are extremely common among the elderly, but Luís Heitor Costa2 information on the use of potentially inappropriate medications (PIMs) with cardiovascular Filipa Alves da Costa3,4 risk is scarce. We aimed to determine the prevalence of PIMs with risk of cardiac and cere- Hubert GM Leufkens5 brovascular adverse events (CCVAEs), including major adverse cardiac and cerebrovascular Ana Paula Martins1 events (MACCE). Patients and methods: A cross-sectional study was performed using a convenience sample 1Research Institute for Medicines (iMED.ULisboa), Faculdade de from four long-term care facilities and one community pharmacy in Portugal. Patients were For personal use only. Farmácia, Universidade de Lisboa, included if they were aged 65 or older and presented at least one type of medication in their 2 Lisboa, Portugal; Serviço de medical and pharmacotherapeutic records from 2015 until December 2017. The main outcome Medicina Interna, Centro Hospitalar Psiquiátrico de Lisboa (CHPL), Lisboa, was defined as the presence of PIMs with risk of MACCE and was assessed by applying a Portugal; 3Centro de Investigação PIM-MACCE list that was developed from a previous study.
    [Show full text]
  • Radish CSA Week 24 Oct
    Weekly Newsletter This week we are honoring: Radish CSA Week 24 Oct. 22– Oct. 28, 2012 CONTENT 1. It’s time to order fresh turkey! "Eating pungent 2. Come to The Inn at East Lynn! radish and drinking 3. Radish Greens Soup hot tea, let the 4. Mango and Radish Salad with starved doctors beg Lime Dressing on their knees”. 5. Buttery Shrimp and Radish Pasta -Chinese proverb- 6. Radish inspired Sandwiches 7. Nutritional Benefits & Usage If you have any questions or requests, please contact us: [email protected]| (202) 253-3737 | www.eastlynnfarm.com It’s Time to Order Your Fresh Turkey! We are taking orders for FRESH THANKSGIVING TURKEYS. These turkeys are raised on pasture, outdoors and allowed to BE ACTIVE AND HEALTHY, so the birds are stronger and have MORE TEXTURED, DELICIOUS MEAT. THE DEADLINE for ordering Turkeys is November 15, 2012, but don’t wait. Our Turkeys are LIMITED and we expect that our supply will end before this date. The cost per turkey is $135*. The Turkeys weight between 16-18 lbs and SERVE 16-18 ADULTS. If you have any questions, please do not hesitate to contact us at: [email protected] * for CSA members only Come and Enjoy The Inn at East Lynn! THE INN AT EAST LYNN is a historic property (circa 1860) on 143 rolling acres nestled between the beautiful Bull Run and Blue Ridge mountains with breathtaking views of the fall in all of its glorious colors. Only 90 minutes from downtown DC and about 50 minutes from Dulles Int’l Airport, it offers a unique venue for those who cherish an ELEGANT AND STILL BUCOLIC country setting.
    [Show full text]